New drug duo aims to rally immune system against rare cancers
NCT ID NCT06116578
Summary
This study aimed to see if giving two cancer drugs before surgery could help the immune system attack specific types of soft tissue sarcoma tumors. It focused on adults with two rare sarcoma types that had a specific immune cell pattern. The goal was to shrink tumors before removal and then continue one drug after surgery to try to prevent the cancer from coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Gustave Roussy
Villejuif, Val De Marne, 94800, France
Conditions
Explore the condition pages connected to this study.